Related Experiment Video
Updated: Oct 26, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
Current status of biosimilars in Turkey: A survey among medical oncologists
Fatih Gürler1, Demet Döndü Kasım2, Bediz Kurt İnci1
1Department of Medical Oncology, Gazi University, Ankara, Turkey.
Introduction:
To evaluate biosimilar understanding and preference trends of medical oncologists in Turkey.
Methods:
A survey consisting of 24 multiple-choice questions with checkbox answers was conducted among medical oncologists. The questionnaire was divided into five parts to some intentions: demographic characteristics, general knowledge about biosimilars, knowledge about local approval and reimbursement issues, individual preference trends, and ranking the knowledge of their own. All answers were analyzed as whole cohort, specialists and fellows.
Results:
Fellows (n = 47) consisted 42%, and academic clinicians (n = 37) consisted 35% of the participants. In the whole cohort, the overall rate of correct answers was 55.1% in the general knowledge about the biosimilars part, and 26.7% in the local approval and reimbursement issues part. At all, 57.7% of the participants declared that they object to switch from a reference product to a biosimilar product. The rate of those who defined themselves as extremely knowledgeable decreased from 8.1% to 2.7% in the whole cohort at the end of the survey.
Conclusion:
The need for more accurate and clarified local regulations and education emerging in the biotechnology era must be met.
More Related Videos
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
10:19Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
Published on: November 10, 2014
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Bioequivalence of Drugs: Drugs with Multiple Indications
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Bioavailability Study Design: Healthy Subjects Versus Patients
Therapeutic Drug Monitoring: Overview and Classification